Evidence mapPaperPMID 41777404Full record

ArticleJournal of geriatric cardiology : JGC2026

CT-derived fractional flow reserve combined with atherosclerotic extent to determine long-term outcomes in diabetic patients with coronary artery disease.

Zhi-Qiang Wang, Zhen-Nan Li, Zhi-Hui Hou, Bin Lu

Abstract read
In one paragraph

Article in Journal of geriatric cardiology : JGC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhi-Qiang WangDepartment of Radiology, Fuwai Hospital, State Key laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhen-Nan LiDepartment of Radiology, Fuwai Hospital, State Key laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhi-Hui HouDepartment of Radiology, Fuwai Hospital, State Key laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Bin LuDepartment of Radiology, Fuwai Hospital, State Key laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: There is still limited data on predictive value of coronary computed tomography angiography (CCTA)-derived fractional flow reserve (CT-FFR) for long term outcomes. We examined the long-term prognostic value of CT-FFR combined with CCTA-defined atherosclerotic extent in diabetic patients with coronary artery disease (CAD). Methods: A retrospective pooled analysis of individual patient data was performed. Deep-learning-based vessel-specific CT-FFR was calculated. All patients enrolled were followed-up for at least 5 years. Predictive abilities for major adverse cardiac events (MACE) were compared among three models (model 1, constructed using clinical variables; model 2, model 1+CCTA-derived atherosclerotic extent (Leiden risk score); and model 3, model 2+CT-FFR. Results: A total of 480 diabetic patients [median age, 61 (55-66) years; 52.9% men] were included. During a median follow-up time of 2197 (2126-2355) days, 55 patients (11.5%) experienced MACE. In multivariate-adjusted Cox models, Leiden risk score (HR: 1.06; 95% CI: 1.01-1.11; Conclusion: In diabetic patients with CAD, CT-FFR provides robust and incremental prognostic information for predicting long-term outcomes. The combined model exhibits improved prediction abilities, which is beneficial for risk stratification.

Identifiers

PMID41777404
PMCPMC12951723

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.